Latest Earnings Results: Q3 '26
Estimated EPS
-$0.15
Reported EPS
-$0.04
Surprise
+73.33%
Estimated Rev
$1M
Reported Rev
$1.14M
Surprise
+13.7%
• Reported GAAP EPS of -$0.04 up 78.95% YoY • Reported revenue of $1.14M down -65.66% YoY • Elutia's automated drug-coating system is designed to support gross margins above 80% at scale and has at least $300M in revenue capacity; NXT-41x full commercial launch is expected in 2028.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | -$0.16 | -- | -- | N/A |
Q3 '26 | -$0.15 | -$0.04 | 73.33% | BEAT |
Q2 '26 | -$0.15 | -$0.17 | -13.33% | MISSED |
Q1 '26 | -$0.15 | -$0.17 | -13.33% | MISSED |
Q4 '25 | -$0.14 | $1.48 | 1157.14% | BEAT |